FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065064 [Registered on: 02/04/2024] Trial Registered Prospectively
Last Modified On: 01/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani 
Study Design  Single Arm Study 
Public Title of Study   A clinical study to evaluate the effect of Unani drug in the Treatment of Chronic Cervicitis 
Scientific Title of Study   A clinical evaluation of polyherbal formulation in the management of Warm -e- unq-ur-rahem muzmin (Chronic Cervicitis)-An open label single arm study. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL   NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.Tanzeela khan 
Designation  PG student 
Affiliation  Ayurvedic and unani Tibbia college and hospital 
Address  Department of ilmul qabalat wa amraz e niswan OPD NO 14, Ayurvedic and Unani Tibbia college and hospital karol bagh New delhi

Central
DELHI
110005
India 
Phone  9084427391  
Fax  -  
Email  tanzeela.khan4001@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr shahana Ayub 
Designation  Assistant professor 
Affiliation  Ayurvedic and Unani tibbia college and hospital 
Address  Department of ilmul qabalat wa amraz e niswan OPD NO 14, Ayurvedic and Unani Tibbia college and hospital karol bagh

Central
DELHI
110005
India 
Phone  8077530209  
Fax  -  
Email  shahanaayub86@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr.Tanzeela khan 
Designation  PG student 
Affiliation  Ayurvedic and Unani tibbia college and hospital 
Address  Department of ilmul qabalat wa amraz e niswan OPD NO 14, Ayurvedic and Unani Tibbia college and hospital karol bagh

Central
DELHI
110005
India 
Phone  9084427391  
Fax  -  
Email  tanzeela.khan4001@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Ayurvedic and Unani Tibbia college and hospital 
Address  Ayurvedic and Unani Tibbia college and Hospital 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tanzeela khan  Ayurvedic and Unani Tibbia College and hospital ,Karol Bagh  Department of Ilmul Qabalat wa Amraze Niswan,OPD no-14,Ayurvedic and Unani Tibbia college and hospital karol bagh
Central
DELHI 
9084427391
-
tanzeela.khan4001@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ayurvedic and Unani Tibbia College karol bagh   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N72||Inflammatory disease of cervix uteri,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Extract of Unani polyherbal formulation Neem (Azadirachta indica) Mundi( Sphaeranthus indicus linn) Kasni (Chicorium intybus) Methi (Trigonella foenum) Revandchini (Rheum emodi) Mazoo (Quercus infectoria) Asgandh (Withania somnifera) filled in capsule form  Two capsules of 500mg twice a day orally for two weeks. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1. Married women in the age group of 18 to 45 years having vaginal discharge.
2. Patient giving history or complaint of the passage of mucopurulent cervical discharge with or without foul smell.
3. Patient with complaints of lower backache.
4. Patient with complaints of intermenstrual spotting and post-coital bleeding.
6. Patient having symptoms of dyspareunia and dysuria.
7. Patient having complaints of vulval Itching.
8. On P/S examination there may be findings of Nabothian follicles, congestion, and hyperplasia of cervix.

 
 
ExclusionCriteria 
Details  1. The patient was unwilling to sign the consent form.
2. The patient has a history of AIDS, syphilis, gonorrhea or any other sexually transmitted disease.
3. History of cardiovascular, renal, liver disease.
4. History of diabetes mellitus .
5. Patients with systemic disease and malignancy.
6. Individuals of alcohol abuse or any other substance abuse.
7. Unmarried and pregnant women.
8. Women having a history of conisation, cryotherapy, and cauterization will also excluded.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
VAS Score (visual analogue scale),PS/PV Examination and PAP Smear will be assessed

 
12 weeks

 
 
Secondary Outcome  
Outcome  TimePoints 
Abnormal cervical discharge,
Lower backache, Vulval Itching,
Foul smell in Vaginal Discharge will be assessed
 
12 weeks 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is an open label single arm trial to validate the efficacy, safety of  of the extract form of Unani polyherbal formulation in the treatment of warm-e-unq-ur-rahem muzmin (chronic cervicitis) and reducing the symptoms of chronic cervicitis . Common complaints of patients include pelvic pain , vaginal discharge ,lower abdomen cramping ,intermenstrual bleeding, spotting with intercourse or dysuria. Cervix acts as a barrier to protect the uterus from entering infections (i.e bacteria ,viruses), if cervix remain unhealthy there is an increased risk of uterine infections. Chronic  cervicitis has become more distressing problem problem, despite  advancement of modern science. Chronic Cervicitis that is caused by Gonorrhea or Chlamydia can spread to uterine lining and fallopian tubes resulting in pelvic inflammatory disease (PID). PID is an infection of the female reproductive organs that can cause fertility issues if left untreated.( eg. ectopic pregnancy, adhesions in uterine cavity ,cervix etc. Several variety of medical therapies are available today for its treatment but no treatment promises complete cure and have some short and long term side effects as well, such as conization, cryotherapy and cauterization and antifungal , antibiotics regimens. The long term use of antibiotics lead to various side effects like  gastrointestinal upset, nausea vomiting, diarrhea, dizziness and antibiotic resistance may also develop. Therefore search for a safe and effective drug is need of the time especially from herbal treasure. Unani scholars have described principles of treatment for the management of chronic cervicitis and many safe and effective single as well as compound drug drugs in classical Unani literature for the same purpose. In this study , we are planning to use extract form of the Unani polyherbal formulation to evaluate the effectiveness of the this composition of drugs.

·       

·       

·       

·      

 
Close